SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The September 2023 quarter revenue stood at Rs. 1635.96 millions, up 11.30% as compared to Rs. 1469.88 millions during the corresponding quarter last year.The Net Loss for the quarter ended September 2023 is Rs. -209.56 millions as compared to Net Profit of Rs. 190.37 millions of corresponding quarter ended September 2022The company reported a degrowth in operating Profit to 198.82 millions from 289.79 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 1635.96 1469.88 11.30 3059.47 2779.94 10.06 6167.34 5201.35 18.57
Other Income 12.59 8.54 47.42 23.61 14.73 60.29 43.20 27.62 56.41
PBIDT 198.82 289.79 -31.39 463.45 525.21 -11.76 1269.82 1079.38 17.64
Interest 7.73 4.49 72.16 12.82 6.31 103.17 24.14 64.07 -62.32
PBDT -126.45 285.30 -144.32 133.09 518.90 -74.35 1245.68 1015.31 22.69
Depreciation 34.03 28.19 20.72 68.28 58.57 16.58 123.42 100.80 22.44
PBT -160.48 257.11 -162.42 64.81 460.33 -85.92 1122.26 914.51 22.72
TAX 49.08 66.74 -26.46 105.77 121.33 -12.82 288.82 195.04 48.08
Deferred Tax 6.54 6.21 5.31 9.85 10.84 -9.13 25.05 27.83 -9.99
PAT -209.56 190.37 -210.08 -40.96 339.00 -112.08 833.44 719.47 15.84
Equity 368.81 364.37 1.22 368.81 364.37 1.22 364.37 364.37 0.00
PBIDTM(%) 12.15 19.72 -38.36 15.15 18.89 -19.82 20.59 20.75 -0.78

Acutaas Chemicals Share Price

2411.15 49.40 (2.09%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×